Testosterone supplementation in patients in best supportive care: impact on quality of life.

Condition studied

Androgen deficiency, palliative care

Investigational medicinal product(s)

Eligibility

Primary endpoint

Best improvement over time in independence using the ADL independence scale in terms of personal hygiene, dressing, going to the toilet, locomotion, continence and eating, Best improvement over time in symptoms of pain, fatigue, sadness, anxiety, drowsiness, appetite, sense of well-being, shortness of breath, bowel movements and strength using the Edmonton Symptom Assessment Scale

Endpoint detail

The average of ADL and Edmonton Symptom Assessment Scale during treatment after baseline. The ADL and Edmonton System Assessment Scale at each time point during treatment, especially at D15., Improvement of quality of life of subjects from the point of view of a proxy using the EQ-5D-3L questionnaire.